TSX News -
FDA Grants Priority Review to HIV Monoclonal Antibody and Long-Acting Investigational Antiretroviral Ibalizumab
MONTREAL, CANADA–(Marketwired – June 30, 2017) – Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that it has been notified by its […]